An autoimmune condition known as immune thrombocytopenic purpura (ITP) is characterized by a low platelet count, purpura, and hemorrhagic episodes caused by antiplatelet autoantibodies. SLE, infectious mononucleosis, lymphomas, chronic lymphocytic leukemia, and other bacterial and viral diseases can all be linked to the same type of autoimmune thrombocytopenia.
In healthy children and young adults, ITP often develops a few weeks after a viral infection. The majority of children gradually recover after a few weeks or months, and splenectomy is rarely required. However, in the first few months following diagnosis, spontaneous remissions in young adults are unusual and sometimes require splenectomy.
Adenocarcinoma, lymphoma, common variable immunodeficiency, and autoimmune illnesses can all cause immune thrombocytopenic purpura in addition to infections (such as the human immunodeficiency virus), cancer, and other diseases (e.g., systemic lupus erythematosus, autoimmune hepatitis, and thyroid disease). These disorders cause the development of anti-platelet antibodies, which then in return destroy platelets.
Drugs may also cause autoimmune thrombocytopenia, such as acetazolamide, aspirin, aminosalicylic acid, carbamazepine, cephalothin, digitoxin, phenytoin, meprobamate, methyldopa, quinidine, rifampin, and sulfamethazine.
Immune thrombocytopenic purpura can be divided into two classifications; acute and chronic. Both sexes are affected by the acute form, which first manifests in childhood and may be preceded by a viral illness. The chronic variant generally does not include a viral infection, affects people between the ages of 20 and 50, and has a 3 to 1 female-to-male ratio. While the platelet levels are near normal at this time, they may manifest with bleeding episodes for months or years. Fewer than 10% of children develop chronic ITP.
1. Specific treatment for ITP is determined by a healthcare provider based on the following parameters –
2. Steroids and intravenous gamma globulin are the two most frequently used types of prompt therapy when treatment is required –
3. Other treatments for ITP may include
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
A small rise in cancer was observed following the 1986 Chernobyl accident.
2.
CAR-T Induces Deep, Durable Remission in Smoldering Myeloma
3.
Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.
4.
Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial
5.
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC
1.
Developmental Regulation of Pediatric Red-Cell Production
2.
Exploring the Benefits of Flexible Sigmoidoscopy: A Revolutionary Way to Detect Colorectal Cancer
3.
Robotic Intratumoral Resection for Organ Preservation: Current Evidence and Clinical Implications
4.
Clinical Analysis of Prostate Cancer
5.
Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Signs and Symptoms of Leukemia
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation